SEC Form 4 · accession 0001209191-16-153928
HARVARD BIOSCIENCE INC · HBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Earl R Lewis
Director
Period of report
Dec 6, 2016
Accepted (ET)
Dec 7, 2016 · 5:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001123494
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Dec 6, 2016 | S | 23,088 | $2.42 | D | 392,012 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2Includes (a) a deferred stock award of 25,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after July 1, 2016, immediately prior to the commencement of such meeting, and (ii) July 1, 2017; (b) a deferred stock award of 6,350 restricted stock units which vests in full on December 31, 2016; and (c) 360,362 shares of common stock held by the Reporting Person.
Remarks
This form has been signed under power of attorney.